These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. Letsinger JA, McCarty MA, Jorizzo JL. J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):500-8. PubMed ID: 15761429 [Abstract] [Full Text] [Related]
6. [Treatment of recurrent buccal aphthosis]. Pinquier L, Revuz J. Ann Dermatol Venereol; 1987 Mar; 114(5):751-7. PubMed ID: 3631851 [No Abstract] [Full Text] [Related]
7. Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis. Mascaro JM, Lecha M, Torras H. Arch Dermatol; 1979 May; 115(5):636-7. PubMed ID: 443847 [No Abstract] [Full Text] [Related]
8. [Evaluation and treatment of aphthous ulcerations of the mouth]. Boisnic S, Tovaru S. Ann Dermatol Venereol; 1991 May; 118(1):53-9. PubMed ID: 1708215 [No Abstract] [Full Text] [Related]
9. [Oral ulcers in HIV infection]. Bassetti S, Courvoisier S, Itin P. Praxis (Bern 1994); 1997 May 21; 86(21):912-3. PubMed ID: 9244978 [No Abstract] [Full Text] [Related]
10. [Aphthosis major treated with thalidomide in a patient with AIDS]. Allegue F, Sarriá Cepeda C, García Rodríguez M. Enferm Infecc Microbiol Clin; 1991 Feb 21; 9(2):133-4. PubMed ID: 1854850 [No Abstract] [Full Text] [Related]
11. [Treatment of aphthosis with thalidomide and with colchicine]. Genvo MF, Faure M, Thivolet J. Dermatologica; 1984 Feb 21; 168(4):182-8. PubMed ID: 6724071 [Abstract] [Full Text] [Related]
12. Management of aphthous ulcers. McBride DR. Am Fam Physician; 2000 Jul 01; 62(1):149-54, 160. PubMed ID: 10905785 [Abstract] [Full Text] [Related]
13. Management of patients with severe oral mucosal disease. Kim Y, Greenberg MS. Alpha Omegan; 2001 Jul 01; 94(2):18-23. PubMed ID: 11480183 [No Abstract] [Full Text] [Related]
14. [Recurrent aphthous stomatitis in Rheumatology]. Riera Matute G, Riera Alonso E. Reumatol Clin; 2011 Jul 01; 7(5):323-8. PubMed ID: 21925448 [Abstract] [Full Text] [Related]
15. [Recurrent aphthosis: safety of low dose thalidomide]. Gil H, Perrin S, Dupond JL, Meaux-Ruault N, Hafsaoui C, Limat S, Magy-Bertrand N. Rev Med Interne; 2010 Jun 01; 31(6):403-5. PubMed ID: 20430488 [Abstract] [Full Text] [Related]
16. Successful management of refractory pediatric-onset complex aphthosis with lenalidomide. Kalampokis I, Rabinovich CE. J Clin Rheumatol; 2014 Jun 01; 20(4):221-3. PubMed ID: 24847750 [Abstract] [Full Text] [Related]
17. [Aphthae and aphthosis: clinical, etiological and therapeutic aspects]. Fiore-Donno G, Samson J, Bernard JP, Lopez-Pardinas M. Schweiz Monatsschr Zahnmed (1984); 1984 Oct 01; 94 Spec No():894-903. PubMed ID: 6595795 [No Abstract] [Full Text] [Related]
18. A new therapeutic candidate for oral aphthous ulcer: Allicin. Jiang XW, Hu J, Mian FI. Med Hypotheses; 2008 Dec 01; 71(6):897-9. PubMed ID: 18771860 [Abstract] [Full Text] [Related]
19. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al. Gompel A, Frances C, Piette JC, Blanc AS, Cordoliani F, Piette AM. Arthritis Rheum; 1999 Oct 01; 42(10):2259-60. PubMed ID: 10524707 [No Abstract] [Full Text] [Related]
20. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience. Cheng S, Murphy R. Clin Exp Dermatol; 2012 Mar 01; 37(2):132-5. PubMed ID: 22007681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]